BioXcel Therapeutics, Inc. Increase (Decrease) in Prepaid Expense
BioXcel Therapeutics, Inc. (BTAI) reported Increase (Decrease) in Prepaid Expense of $666.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2018-08-08
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2018-06-30 was -$139.00K.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2018-03-31 was $805.00K.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2017-06-30 was -$1.00K.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2017-03-31 was -$1.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month |
|---|---|---|
| 2018-06-30 | -$139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $666.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $805.00K 10-Q · filed 2018-05-14 | |
| 2017-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$2.00K 10-Q · filed 2018-08-08 |
| 2017-03-31 | -$1.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |